These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19384945)

  • 1. Mass screening for colorectal cancer is not justified in most developing countries.
    Lambert R; Sauvaget C; Sankaranarayanan R
    Int J Cancer; 2009 Jul; 125(2):253-6. PubMed ID: 19384945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening: a global overview of existing programmes.
    Schreuders EH; Ruco A; Rabeneck L; Schoen RE; Sung JJ; Young GP; Kuipers EJ
    Gut; 2015 Oct; 64(10):1637-49. PubMed ID: 26041752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
    Hardcastle JD; Chamberlain JO; Robinson MH; Moss SM; Amar SS; Balfour TW; James PD; Mangham CM
    Lancet; 1996 Nov; 348(9040):1472-7. PubMed ID: 8942775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to colorectal cancer screening among Medicare consumers.
    Klabunde CN; Schenck AP; Davis WW
    Am J Prev Med; 2006 Apr; 30(4):313-9. PubMed ID: 16530618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening.
    Bretthauer M
    J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention and early detection of colorectal cancer in average risk population--summary of a meeting and the Israeli gastroenterology policy].
    Strul H; Elyakim R; Halpern Z; Arber N
    Harefuah; 2003 Mar; 142(3):223-6, 236. PubMed ID: 12696479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and overweight associated with lower rates of colorectal cancer screening in Switzerland.
    Fischer R; Collet TH; Zeller A; Zimmerli L; Gaspoz JM; Giraudon K; Rodondi N; Cornuz J
    Eur J Cancer Prev; 2013 Sep; 22(5):425-30. PubMed ID: 23512069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
    Tinmouth J; Lansdorp-Vogelaar I; Allison JE
    Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy.
    Brenner H; Chang-Claude J; Jansen L; Knebel P; Stock C; Hoffmeister M
    Gastroenterology; 2014 Mar; 146(3):709-17. PubMed ID: 24012982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for colorectal cancer.
    Hakama M; Hoff G; Kronborg O; Påhlman L
    Acta Oncol; 2005; 44(5):425-39. PubMed ID: 16118076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon and rectum cancer in Thailand: an overview.
    Khuhaprema T; Srivatanakul P
    Jpn J Clin Oncol; 2008 Apr; 38(4):237-43. PubMed ID: 18356191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for colorectal cancer screening.
    Bretthauer M
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
    Hofbauer F; Mach K; Egermann G
    Wien Klin Wochenschr; 1991; 103(10):288-95. PubMed ID: 1858377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From screening criteria to colorectal cancer screening: what can New Zealand learn from other countries?
    Shaw C; Cunningham R; Sarfati D
    N Z Med J; 2008 Aug; 121(1279):84-95. PubMed ID: 18709051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rise of Colorectal Cancer in Asia: Epidemiology, Screening, and Management.
    Onyoh EF; Hsu WF; Chang LC; Lee YC; Wu MS; Chiu HM
    Curr Gastroenterol Rep; 2019 Jul; 21(8):36. PubMed ID: 31289917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for colorectal cancer: what is the most effective strategy?].
    Merzenich H; Giersiepen K; Kieschke J; Zeeb H
    Gesundheitswesen; 2005 Nov; 67(11):803-8. PubMed ID: 16308813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a selective screening for colorectal carcinoma: the Taiwan Multicenter Cancer Screening (TAMCAS) project.
    Chen TH; Yen MF; Lai MS; Koong SL; Wang CY; Wong JM; Prevost TC; Duffy SW
    Cancer; 1999 Oct; 86(7):1116-28. PubMed ID: 10506694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.